The differential regulation of BDNF and TrkB levels in juvenile rats after four days of escitalopram and desipramine treatment

Neuropharmacology

Volumn 54, Issue 2, 2008, Pages 251-257

  Kozisek, Megan E ^a   Middlemas, David ^a   Bylund, David B ^a  

^a NEBRASKA MEDICAL CENTER   (United States)

Author keywords

BDNF; Depression; Desipramine; Escitalopram; Norepinephrine; Serotonin; TrkB

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; DESIPRAMINE; ESCITALOPRAM; MESSENGER RNA; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG EFFECT; FRONTAL CORTEX; HIPPOCAMPUS; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT;

AGING; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITALOPRAM; DESIPRAMINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; INJECTIONS, INTRAPERITONEAL; PREFRONTAL CORTEX; RATS; RECEPTOR, TRKB; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEROTONIN UPTAKE INHIBITORS;

EID: 38149024046     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.08.001     Document Type: Article

References (37)

1. Altar C.A., Laeng P., Jurata L.W., Brockman J.A., Lemire A., Bullard J., Bukhman Y.V., Young T.A., Charles V., and Palfreyman M.G. Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J. Neurosci. 24 (2004) 2667-2677
2. Altar C.A., Whitehead R.E., Chen R., Wortwein G., and Madsen T.M. Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol. Psychiatry 54 (2003) 703-709
3. Angelucci F., Aloe L., Jimenez-Vasquez P., and Mathe A.A. Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depression. Int. J. Neuropsychopharmacol. 6 (2003) 225-231
4. Argenti D., and D'Mello A.P. Design of a desipramine dosing regimen for the rapid induction and maintenance of maximal cortical beta-adrenoceptor downregulation. Neuropharmacology 33 (1994) 1117-1124
5. Birmaher B., Brent D., Bernet W., Dunne J., Adair M., Arnold V., Benson S., Bukstein O., Kinlan J., McClellan J., and Rue D. Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. J. Am. Acad. Child Adolesc. Psychiatry 37 (1998) 63S-83S
6. Burke S.N., and Barnes C.A. Neural plasticity in the ageing brain. Nat. Rev. Neurosci. 7 (2006) 30-40
7. Castren E. Neurotrophins as mediators of drug effects on mood, addiction, and neuroprotection. Mol. Neurobiol. 29 (2004) 289-302
8. Castren E. Neurotrophic effects of antidepressant drugs. Curr. Opin. Pharmacol. 4 (2004) 58-64
9. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., and Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry 50 (2001) 260-265
10. Coppell A.L., Pei Q., and Zetterstrom T.S. Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology 44 (2003) 903-910
11. Costello E.J., Mustillo S., Erkanli A., Keeler G., and Angold A. Prevalence and development of psychiatric disorders in childhood and adolescence. Arch. Gen. Psychiatry 60 (2003) 837-844
12. De F.G., Carney S.L., Robinson C.S., Destexhe E.J., Tomlinson R., Hicks C.A., Murray T.K., Gaillard J.P., Deville C., Xhenseval V., Thomas C.E., O'Neill M.J., and Zetterstrom T.S. Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment. Neuroscience 128 (2004) 597-604
13. Dias B.G., Banerjee S.B., Duman R.S., and Vaidya V.A. Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology 45 (2003) 553-563
14. Duman R.S., Heninger G.R., and Nestler E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry 54 (1997) 597-606
15. Duman R.S., and Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 59 (2006) 1116-1127
16. Duman R.S., Nakagawa S., and Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 25 (2001) 836-844
17. Hazell P., O'Connell D., Heathcote D., Robertson J., and Henry D. Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis. BMJ 310 (1995) 897-901
18. Holoubek G., Noldner M., Treiber K., and Muller W.E. Effect of chronic antidepressant treatment on beta-receptor coupled signal transduction cascade. Which effect matters most?. Pharmacopsychiatry 37 Suppl 2 (2004) S113-S119
19. Huang E.J., and Reichardt L.F. Neurotrophins: roles in neuronal development and function. Ann. Rev. Neurosci. 24 (2001) 677-736
20. Ivy A.S., Rodriguez F.G., Garcia C., Chen M.J., and Russo-Neustadt A.A. Noradrenergic and serotonergic blockade inhibits BDNF mRNA activation following exercise and antidepressant. Pharmacol. Biochem. Behav. 75 (2003) 81-88
21. Jacobsen J.P., and Mork A. The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels. Brain Res. 1024 (2004) 183-192
22. Kozisek M.E., Deupree J.D., Burke W.J., and Bylund D.B. Appropriate dosing regimens for treating juvenile rats with desipramine for neuropharmacological and behavioral studies. J. Neurosci. Methods 163 (2007) 83-91
23. Kratochvil C.J., Vitiello B., Walkup J., Emslie G., Waslick B.D., Weller E.B., Burke W.J., and March J.S. Selective serotonin reuptake inhibitors in pediatric depression: is the balance between benefits and risks favorable?. J. Child Adolesc. Psychopharmacol. 16 (2006) 11-24
24. Lewinsohn P.M., Solomon A., Seeley J.R., and Zeiss A. Clinical implications of "subthreshold" depressive symptoms. J. Abnorm. Psychol. 109 (2000) 345-351
25. Lindefors N., Brodin E., and Metsis M. Spatiotemporal selective effects on brain-derived neurotrophic factor and trkB messenger RNA in rat hippocampus by electroconvulsive shock. Neuroscience 65 (1995) 661-670
26. Manji H.K., Drevets W.C., and Charney D.S. The cellular neurobiology of depression. Nat. Med. 7 (2001) 541-547
27. Mayberg H.S. Positron emission tomography imaging in depression: a neural systems perspective. Neuroimaging Clin. N. Am. 13 (2003) 805-815
28. McAllister A.K., Lo D.C., and Katz L.C. Neurotrophins regulate dendritic growth in developing visual cortex. Neuron 15 (1995) 791-803
29. Mork A., Kreilgaard M., and Sanchez C. The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats. Neuropharmacology 45 (2003) 167-173
30. Nestler E.J., Gould E., Manji H., Buncan M., Duman R.S., Greshenfeld H.K., Hen R., Koester S., Lederhendler I., Meaney M., Robbins T., Winsky L., and Zalcman S. Preclinical models: status of basic research in depression. Biol. Psychiatry 52 (2002) 503-528
31. Nibuya M., Morinobu S., and Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15 (1995) 7539-7547
32. Reed, A.L., Happe, H.K., Petty, F., Bylund, D.B. Juvenile rats in the forced-swim test model the human response to antidepressant treatment for pediatric depression. Psychopharmacology, submitted for publication.
33. Russo-Neustadt A., Ha T., Ramirez R., and Kesslak J.P. Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model. Behav. Brain Res. 120 (2001) 87-95
34. Saluja G., Iachan R., Scheidt P.C., Overpeck M.D., Sun W., and Giedd J.N. Prevalence of and risk factors for depressive symptoms among young adolescents. Arch. Pediatr. Adolesc. Med. 158 (2004) 760-765
35. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., and Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 22 (2002) 3251-3261
36. Siuciak J.A., Lewis D.R., Wiegand S.J., and Lindsay R.M. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol. Biochem. Behav. 56 (1997) 131-137
37. Xu H., Steven R.J., and Li X.M. Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2 and Cu/Zn-SOD in rat hippocampus. Neuropsychopharmacology 28 (2003) 53-62